The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group was established in 2008 as a cooperative platform for physicians, scientists and healthcare workers from institutions in the WHO designated Eastern Mediterranean area with the goal of sharing experience, initiation of cooperative trials and establish common strategy to achieve optimization in the field of HSCT.
Saudi Society of Hematology
Working together through sharing experience and research to improve the quality in diagnosis & treatment.
Working together to minimize/eradicate blood diseases in the Kingdom of Saudi Arabia by 2030
Hematology / Oncology and Stem Cell therapy
Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of…/p>
Journal of applied Hematology
Journal of Applied Hematology, an official publication of Saudi Scientific Society of Hematology is a peer-reviewed on-line journal, published quarterly with print on demand compilation of issues. The journal is one of the few journals in the Middle East with focus on issues relating to hematological disorders and their treatment in the region.
The Asia-Pacific Blood and Marrow Transplantation Group (APBMT) was initiated by transplant physicians from Australia, China, Hong Kong, India, Japan, Republic of Korea, Malaysia and Taiwan in 1990 to share the information regarding hematopoietic stem cell transplantation (HSCT) and promote collaborative basic and clinical studies.
The CIBMTR® (Center for International Blood and Marrow Transplant Research®) is a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW).
We are a community of healthcare professionals focused on innovation, research and the advancement of cellular and stem cell-based therapies to save and improve the lives of patients with blood-related disorders.
European Leukemia Net
220 Participating Centers in 44 Countries with more than 1000 researchers and clinicians are cooperating in the European LeukemiaNet. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN)…
The International CML Foundation (iCMLf) is a Foundation established in 2009 by a group of hematologists with a strong interest in CML. Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales, however our charter is global.
The MDS Foundation is a global non-profit advocacy organization that for over 25 years has supported patients and their families as well as healthcare providers in the fields of MDS and its related diseases….
AML Global Portal
The AML Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management….